Riskpilot← Back to searchSign inGet full accessOSLO HUDKLINIKK AS
ASActiveOrg 998242908Fjordgata 50, 7010 TrondheimMedical specialists activities · NACE 8622Est. 20120 employees
Revenue 2023
NOK 0
EBITDA margin
—
+90% vs 2022
Equity ratio
-105.3%
Financial strength
Net profit 2023
NOK -722K
+89% vs 2022
| Revenue | NOK 0 | — |
| EBITDA | NOK -642K | +90% |
| Net profit | NOK -722K | +89% |
| Total assets | NOK 5,2M | -2% |
| Equity | NOK -5,4M | -15% |
| Employees | 0 | — |
Legal name
OSLO HUDKLINIKK AS
Org number
998242908
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
14. april 2012
Share capital
NOK 80 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet og produktsalg med alt som inngår i den forbindelse, samt investering i eierandeler i andre selskaper.
Address
Fjordgata 50, 7010 Trondheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −45 | −30 | −35 | −6 402 | −642 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −45 | −30 | −35 | −6 402 | −642 |
| Net financials | −0 | −2 | −4 | −0 | −81 |
| Profit before tax | −45 | −32 | −38 | −6 402 | −722 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −45 | −32 | −38 | −6 402 | −722 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 1 787 | 1 901 | 5 169 | 5 246 | 5 165 |
| Equity | 1 756 | 1 724 | 1 686 | −4 716 | −5 438 |
| Long-term debt | 8 | 162 | 3 462 | 9 962 | 9 962 |
| Short-term debt | 22 | 15 | 20 | 0 | 641 |
| Total debt | 31 | 177 | 3 483 | 9 962 | 10 603 |
EBITDA margin
-64157400.0%
This company
15.8%
Market median
-406059594% vs market
20192023
Equity ratio
-105.3%
This company
38.2%
Market median
-376% vs market
20192023
Return on equity
-72229200.0%
This company
18.4%
Market median
-392550100% vs market
20192023
Net profit margin
-72229200.0%
This company
8.1%
Market median
-891718619% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
1.95×
This company
0.62×
Market median
-215% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KM Contact Person | Contact Person | 2023 |
| Former (1) | ||
AD Deputy Member | Deputy Member | 2012 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Chairman | 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OSLO HUDKLINIKK AS 
Q-Thera AsBoard members of OSLO HUDKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alicia De La Parte Lopez | Deputy Member | 0 companies |
| Kristian Meling Nygård | Contact Person | 0 companies |
| Ole Martin Rørdam | Chairman | 0 companies |
| Jean-Marie Bettinger | Chairman | 0 companies |